Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

Clinical trial NCT05599412 · RECRUITING

Trial details

NCT number: NCT05599412
Sponsor: Pfizer
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic ALK+ Non Small Cell Lung Cancer

Start date: 2023-05-22
Primary completion: 2028-01-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.